珍宝岛：控股股东可交债换股价格将从13.35元/股下调至12.35元

Core Viewpoint - Heilongjiang Zhenbaodao Pharmaceutical Co., Ltd. announced an adjustment to the conversion price of its convertible bond "23 Chuang 01 EB" to protect the interests of bondholders [1] Group 1: Bond Details - The convertible bond was issued on April 11, 2023, with a total scale of 910 million yuan and a maturity of 3 years [1] - The conversion price has been revised from 13.35 yuan per share to 12.35 yuan per share, effective from August 27 [1] Group 2: Corporate Actions - The adjustment was approved by the board of directors on August 11, and subsequently agreed upon in a bondholders' meeting on August 20 [1] - The pledged account for the shares still meets the conversion demand after the price adjustment [1]